Ibane Abasolo

📅 Hoy es el Día Mundial de la Investigación en #Cáncer, una jornada para visibilizar la ciencia frente a este conjunto de enfermedades 

🔬 Te contamos algunas de las investigaciones oncológicas del #CSIC para mejorar la salud de las personas

#WorldCancerResearchDay 🧵👇

#proud_supervisor #thesis #Lsd #fabry

Thanks also to the incredible committee: Maria Sancho, Victor J. Lopez & Julia Lorenzo, for their insightful discussion and the time they generously dedicated to Marc’s work.

Marc Moltò-Abad defended his PhD brilliantly today!
It’s been a long road, but I am grateful for having had the chance to see him grow as a sicentist.
Congrats Dr. Moltò-Abad! 🥳

Preclinical evaluation of several polymeric micelles identifies Soluplus®-docetaxel as the most effective candidate in multiple glioblastoma models Glioblastoma multiforme (GBM) is one of the most lethal cancers, with limited treatment options due to the blood-brain barrier (BBB), systemic toxicit…

www.sciencedirect.com/science/arti...

Gemcitabine and miRNA34a mimic codelivery with magnetic nanoparticles enhanced anti-tumor effect against pancreatic cancer Pancreatic ductal adenocarcinoma is a highly aggressive cancer with a low survival rate. Thus, efforts are needed to develop more effective treatments…

www.sciencedirect.com/science/arti...

April has been a productive month for our team, with two publications now out in the JCR.
These studies are strong examples of what collaborative research across disciplines can accomplish. Many thanks and congrats to all of them!
#nanomedicine #drugdelivery #glioblastoma #pancreaticcancer
👇👇

Do not miss this opportunity! You could end up in our lab! 🎉🔬 #CSIC #IQAC #NM4T

Please share the feed with friends and colleagues or directly email me if you are interested. ibane.abasolo@iqac.csic.es

We are applying to three competitive PhD funding calls.
o CSIC’s JAE INTRO and JAE ICU’s grants. Short-term fellowships (5–7 months) designed to help candidates preparing applications for longer-term PhD funding opportunities.
o AGAUR’s FI-STEP call, funding PhD candidates for 3 years.

Selected candidates will participate in one of the following projects:
1. Production and evaluation of extracellular vesicles for the enzyme replacement therapies in lysosomal storage disorders.
2. Development of targeted biodegradable nanomedicines for the treatment of cancer
#Cancer #LSDs #EVs

Applicants must
- Be citizens of an EU country
- Have obtained already or be on track to complete a Master’s degree in biomedical sciences by Sept 15, 2025
- Have a strong academic record (GPA > 8/10)
#Nanomedicine #DrugDelivery #BiomedicalResearch #PhDopportunity #Barcelona #IQAC #CSIC

We are looking for 2 PhD candidates to join exciting projects in nanomedicine and drug delivery.
If you are enroled in a Ms program and are passionate about translational research, this could be for you!
📩 Interested? DM or email me ibane.abasolo@iqac.csic.es
Deadline: April 1, 2025 #PhDposition

Hoy, 3 miembros de la RER-CSIC: Luisa María Botella Cubells (CIB), Pascual (IBV) y Lluís Montoliu (CNB) @lluismontoliu.bsky.social participan en la mesa redonda "Enfermedades raras, pero no olvidadas", junto a Almudena Amaya (FEDER) en el Congreso de Investigación Biomédica CIB2025 en Valencia

Hoy es 11 de febrero y celebramos el día internacional de la mujer y la niña en la ciencia. Desde el @csic.es se han organizado muchas actividades en diversos centros de nuestra institución, que están detalladas en esta web.
www.csic.es/es/actualida...

Para reflexionar de cara al #11F…

My kudos to Gio Lerussi and Vero Villagrasa. You've done amaizing job with this review!! 👏

This review compiles ALL published work on using EVs as drug delivery systems for improving the enzyme replacement therapy in disease such Fabry, Gauche, Batten, cystynosis and many others.
If you want to know more about LSDs, EVs or protein delivery, this IS your paper.

Extracellular Vesicles as Tools for Crossing the Blood–Brain Barrier to Treat Lysosomal Storage Diseases Extracellular vesicles (EVs) are nanosized, membrane-bound structures that have emerged as promising tools for drug delivery, especially in the treatment of lysosomal storage disorders (LSDs) with cen...

Review paper, just out of the oven! 🎂📑
If you are interested on extracellular vesicles, protein delivery, brain targeting or lysosomal storage disorders, have a look! 👇
www.mdpi.com/2075-1729/15...

More than 40% of postdocs leave academia, study reveals Publishing highly cited papers helps postdoctoral researchers to land a faculty job.

More than 40% of postdocs leave academia, study reveals www.nature.com/articles/d41...

This was a huge collaborative work with groups form This collaborative effort includes contributions from VHIR, CIBER-BBN, IMDEA, TC Dublin, RCL...
It’s always a pleasure to collaborate with such excellent partners and friends! 👩‍🔬

Our findings highlight the synergistic effect of combining chemotherapy 💊with hyperthermia 🔥, enhancing therapeutic efficacy through the disruption of tumor stroma and direct action on cancer cells. Results were essential for the approval of the first clinical study using MNP in pancreatic cancer

Preclinical Development of Magnetic Nanoparticles for Hyperthermia Treatment of Pancreatic Cancer Pancreatic ductal adenocarcinoma (PDAC) is a very challenging disease with a very poor prognosis. It is characterized by a dense desmoplastic stroma that hampers drug penetration and limits the effect...

First paper in 2025! 🎉 "Preclinical Development of Magnetic Nanoparticles for Hyperthermia Treatment of Pancreatic Cancer." 🌟 Read it here: pubs.acs.org/doi/10.1021/...

Hi all 👋
My first post here.
I'm very happy to see that the science community is active in Bluesky.
See you around!